ZTEKF Zentek Ltd. IFRS Annual reports only
Miscellaneous Chemical Products · OTC · SEC CIK 1904501 · Reporting currency CAD · Fiscal year ends 03/31
Financial factors as of 2025-03-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: CAD | FY2025*2025-03-31 | FY2024*2024-03-31 | FY2023*2023-03-31 | FY2022*2022-03-31 | FY2021*2021-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 872,495 | 29,816 | 72,855 | 347,183 | 2,355 |
| Cost of revenue | 644,610 | 289,011 | — | — | — |
| Gross profit | 227,885 | -259,195 | — | — | — |
| R&D expense | 465,653 | 1.78M | 1.65M | 1.54M | 0 |
| Operating income | -9.61M | -12.40M | -14.97M | -12.56M | -4.31M |
| Interest expense | 91,323 | 107,373 | 120,624 | 63,777 | 6,460 |
| Income tax | 0 | 0 | 0 | 0 | 0 |
| Net income | -10.04M | -11.70M | -14.41M | -31.69M | -3.87M |
| EBITDA | -9.01M | -11.79M | -14.43M | — | — |
| EPS (basic) | -0.10 | -0.12 | -0.14 | -0.34 | — |
| EPS (diluted) | -0.10 | -0.12 | -0.14 | -0.34 | 0.05 |
| Balance sheet | |||||
| Cash & equivalents | 121,481 | 3.52M | 10.36M | 26.68M | 3.09M |
| Receivables | 1.20M | 296,530 | 569,008 | 656,164 | 119,349 |
| Inventory | 887,509 | 1.42M | 2.85M | 665,572 | 0 |
| Current assets | 4.37M | 6.25M | 17.95M | 31.96M | 3.39M |
| PP&E, netmay include right-of-use assets (IFRS) | 5.28M | 7.77M | 8.34M | 6.03M | 705,221 |
| Total assets | 18.40M | 22.59M | 33.29M | 44.98M | 30.25M |
| Current liabilities | 3.49M | 1.82M | 2.42M | 2.30M | 2.51M |
| Short-term debt | 346,747 | 498,613 | 998,080 | 950,930 | 0 |
| Long-term debt | 0 | 259,114 | 0 | 998,070 | 0 |
| Total debt | 346,747 | 757,727 | 998,080 | 1.95M | 0 |
| Total liabilities | 3.65M | 2.41M | 2.90M | 3.44M | 2.79M |
| Shareholders' equity | 14.75M | 20.17M | 30.38M | 41.55M | 27.46M |
| Net debt | 225,266 | -2.76M | -9.36M | -24.73M | -3.09M |
| Cash flow statement | |||||
| Operating cash flow | -6.28M | -8.05M | -12.96M | -7.99M | -1.79M |
| Capital expenditure | 1,398 | 320,099 | 2.27M | 3.99M | 254,282 |
| Free cash flow | -6.28M | -8.37M | -15.23M | -11.97M | -2.05M |
| Investing cash flow | 358,651 | 1.88M | -2.31M | -7.25M | — |
| Financing cash flow | 2.52M | -665,470 | -1.05M | 38.82M | 5.31M |
| Depreciation & amortization | 600,322 | 613,714 | 539,693 | — | — |
| Stock-based compensation | 1.53M | 1.79M | 3.20M | 4.73M | 2.02M |
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.